Key result
Myxoid adrenocortical adenoma can be distinguished from metastatic mucinous adenocarcinoma by extracellular myxoid material, centrally located nuclei, and positive immunoreactivity to specific markers.
Case Report (n=1)
This report describes the first cytopathological study of a myxoid adrenocortical adenoma with a pseudoglandular component, providing key features to differentiate it from metastatic mucinous adenocarcinoma.
May aid cytopathologists in rare adrenal differentials; leaves open validation in larger series.
Myxoid adrenocortical tumors are extremely rare neoplasms with only nine adenomas and eleven carcinomas reported in the literature. They occasionally have a pseudoglandular component resembling metastatic mucinous adenocarcinoma in the adrenal gland. However the cytological features of this unusual tumor have not been previously described. We report here the first cytopathological study of a myxoid adrenocortical adenoma with a pseudoglandular component, contributing especially to the differential diagnosis from metastatic mucinous adenocarcinoma. Two major cytopathological features distinguishing myxoid adrenocortical adenoma from metastatic mucinous adenocarcinoma in the adrenal gland are: (1) the myxoid material is found only in the extracellular space, and not in the cytoplasm; and (2) nuclei are usually located in the central portion of the cytoplasm, and not compressed to the periphery. Careful observation of these cytological features and positive immunoreactivity to Melan A, alpha-inhibin and synaptophysin can lead to the correct diagnosis.
No takes yet. Share an insight, caveat, or question.
Ishida et al. (2008) conducted a case report in Myxoid adrenocortical adenoma with a pseudoglandular component (n=1). Cytopathological evaluation vs. Metastatic mucinous adenocarcinoma was evaluated on Cytological features distinguishing myxoid adrenocortical adenoma from metastatic mucinous adenocarcinoma. Myxoid adrenocortical adenoma can be distinguished from metastatic mucinous adenocarcinoma by extracellular myxoid material, centrally located nuclei, and positive immunoreactivity to specific markers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: